节点文献

子宫颈癌术后规范化治疗对肿瘤学预后影响研究

Effect of standardization of postoperative adjuvant therapy on oncology outcome in patients with cervical cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 尹钊红黎志强康山杨鹰郭建新詹雪梅李朋飞刘佳琪郎景和刘萍陈春林

【Author】 YIN Zhao-hong;LI Zhi-qiang;KANG Shan;YANG Ying;GUO Jian-xin;ZHAN Xue-mei;LI Peng-fei;LIUJia-qi;LANG Jing-he;LIU Ping;CHEN Chun-lin;Department of Obstetrics and Gynecology,Nanfang Hospital,Southern Medical University;

【通讯作者】 刘萍;陈春林;

【机构】 南方医科大学南方医院妇产科河北医科大学第四医院妇科陆军军医大学新桥医院妇产科解放军陆军特色医学中心(大坪医院)妇产科江门市中心医院妇科中国医学科学院北京协和医院妇产科

【摘要】 目的探讨国际妇产科联盟(FIGO)2018分期ⅠA~ⅡA期子宫颈癌患者术后辅助治疗的规范性对肿瘤学结局的影响。方法在中国子宫颈癌临床诊疗项目大数据库中筛选FIGO 2018ⅠA~ⅡA期接受规范手术治疗的子宫颈癌患者,比较术后治疗规范与术后治疗不规范患者的5年总体生存率(OS)和无瘤生存率(DFS)。结果 (1)纳入符合入组标准的FIGO 2018ⅠA~ⅡA期接受规范手术治疗5638例(包括术后治疗规范2205例,术后治疗不规范3433例),中位随访时间44个月(术后治疗规范组43个月,术后治疗不规范组46个月)。(2)Kaplan-Meier生存分析显示,术后治疗规范组肿瘤学结局明显优于术后治疗不规范组(OS:95.7%vs. 88.7%,P<0.001;DFS:92.1%vs.83.4%,P<0.001)。(3)Cox多因素分析显示,术后治疗不规范组发生死亡的风险是术后治疗规范组的1.556倍(HR=1.556,95%CI 1.135~2.133,P=0.006),发生复发/死亡的风险是术后治疗规范组的1.391倍(HR=1.391,95%CI1.113~1.737,P=0.004)。结论从肿瘤学预后分析,术后治疗规范患者肿瘤学结局优于术后治疗不规范者,故术后治疗规范性需要得到重视。

【Abstract】 Objective To explore the effect of standardization of postoperative adjuvant therapy on oncology outcome in patients with FIGO 2018 stage I A-II A cervical cancer.Methods Patients with cervical cancer in the new stage I AII A of FIGO 2018 were selected from Four C Database.The 5-year OS and DFS of patients with standardized and nonstandardized postoperative treatments were compared.Results(1)Totally 5638 patients with cervical cancer were in FIGO 2018 stage Ⅰ A-Ⅱ A enrolled(standardized postoperative treatment 2205,non-standardized postoperative treatment 3433).The median follow-up period was 44 months(standardized postoperative treatment 43 months,nonstandardized postoperative treatment 46 months).(2) Kaplan-Meier survival analysis showed that the oncology outcome of the standardized postoperative treatment group was significantly better than that of the non-standardized postoperative treatment group(OS:95.7% vs.88.7%,P <0.001;DFS:92.1% vs.83.4%,P <0.001).(3) Cox multivariate analysis showed that the risk of death in the non-standardized postoperative treatment group was 1.556 times higher than that in the standardized postoperative treatment group(HR=1.556,95%CI 1.135-2.133,P=0.006),and the risk of recurrence/death was 1.391 times higher(HR=1.391,95%CI 1.113-1.737,P=0.004).Conclusion From the perspective of oncology outcome,the oncology outcome of the standardized postoperative treatment group is better than that of the non-standardized postoperative treatment group.The standardization of postoperative treatment needs to be paid attention to.

【基金】 十二五国家科技支撑计划(2014BAI05B03);国家自然科学基金(81272585);广州市科技计划(158100075);广东省教育厅高水平大学建设经费南方医科大学临床研究启动项目(LC2016ZD019)
  • 【文献出处】 中国实用妇科与产科杂志 ,Chinese Journal of Practical Gynecology and Obstetrics , 编辑部邮箱 ,2022年01期
  • 【分类号】R737.33
  • 【被引频次】1
  • 【下载频次】315
节点文献中: 

本文链接的文献网络图示:

本文的引文网络